Login

Reduced Neutralization of SARS-CoV-2 B.1.1.7 Variant from Naturally Acquired and Vaccine Induced Antibody Immunity

2019-20 coronavirus outbreak
DOI: 10.2139/ssrn.3775873 Publication Date: 2021-02-04T23:42:37Z
Abstract Supplemental Material References Cited by
AUTHORS (53)
Piyada Supasa
Daming Zhou
Wanwisa Dejniratt...
Chang Liu
Alexander J. Mentzer
Helen M. Ginn
Yuguang Zhao
Helen ME Duyvesteyn
Rungtiwa Nutalai
Aekkachai Tuekpra...
Beibei Wang
Guido C. Paesen
Jose Slon-Campos
Cesar Lopez-Camacho
Bassam Hallis
Naomi Coombes
Kevin Bewley
Sue Charlton
Thomas S. Walter
Eleanor Barnes
Susanna Dunachie
Donal Skelly
Sheila Lumley
Natalie Baker
Imam Shaik
Holly Humphries
Kerry Godwin
Nick Gent
Alex Sienkiewicz
Christina Dold
Robert Levin
Tao Dong
Andrew Pollard
Julian Knight
Paul Klenerman
Derrick W. Crook
Teresa Lambe
Elizabeth Clutter...
Sagida Bibi
Amy Flaxman
Mustapha Bittaye
Sandra Belij-ramm...
Sarah C. Gilbert
David R. Hall
Mark A. Williams
Neil G. Paterson
William James
Miles W. Carroll
Elizabeth E. Fry
Juthathip Mongkol...
Jingshan Ren
David I. Stuart
Gavin R. Screaton
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (2)
EXTERNAL LINKS
CROSSREF - Publications  OPENAIRE - Products  OPENALEX - Publications 
PlumX Metrics
Reduced Neutralization of SARS-CoV-2 B.1.1.7 Variant from Naturally Acquired and Vaccine Induced Antibody Immunity 
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....

Powered by

  • AIX SEMS NFDI4DS

Legal

  • Impressum Datenschutz

Connect